Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

BMS image

BMS unveils $165m expansion in Puerto Rico

July 17, 2012
Manufacturing and Production BMS, Puerto Rico, diabetes, manufacturing

A facility operated by Bristol-Myers Squibb in Puerto Rico stands to benefit from a $165 million investment programme that will …

News

Boehringer collaborates for online ‘beyond pill’ plan

July 11, 2012
Medical Communications Boehringer, diabetes, digital, healthrageous

Boehringer Ingelheim is collaborating with US digital health specialist Healthrageous on a scheme to help type II diabetes sufferers manage …

News
Janssen image

Janssen buys into regenerative diabetes portfolio

July 11, 2012
Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes

Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …

News

R&D, East & West: Lilly invests in its global research network

July 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …

Feature
sanofi website

Positive data for Sanofi’s diabetes drug

June 13, 2012
Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …

News

BMS invests $15 million in Asian diabetes programme

June 11, 2012
Sales and Marketing Asia, BMS, China, India, Onglyza, diabetes

Bristol-Myers Squibb has invested $15 million into its ‘Together on Diabetes’ campaign in India and China. Together on Diabetes is …

News

AstraZeneca diabetes drug recommended in Europe

April 23, 2012
Sales and Marketing AstraZeneca, CHMP, FDA, Merck, WHO, diabetes

AstraZeneca and Bristol-Myers Squibb’s new type II diabetes treatment Forxiga has received a positive opinion by European regulators.  The European …

News

Diabetes UK launches new peer support service

April 16, 2012
Diabetes UK, diabetes, peer support

Diabetes UK has launched a new support service that puts people with diabetes in touch with others who have the …

News

Januvia gains renal impairment licence in UK

April 13, 2012
Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment

Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …

News
Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012
Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

News
Diabetes nest image

Roche sponsors Twitter-based diabetes community

April 5, 2012
Medical Communications Ignite Health, Roche, Twitter, diabetes

Roche is to sponsor a Twitter-based site devoted talk about diabetes, furthering its close links with online commentators.  ‘Diabetes Nest’ …

News
GSK image

GSK’s diabetes drug misses goal

April 4, 2012
Research and Development, Sales and Marketing Bydureon, GSK, Victoza, albiglutide, diabetes

GlaxoSmithKline has insisted its new long-acting Type 2 diabetes drug albiglutide remains on course for filing following topline results from …

News

Amylin dismisses BMS acquisition deal

March 30, 2012
Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly

Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …

News
Boehringer building image

Trajenta article lands Boehringer in hot water

March 19, 2012
Sales and Marketing ABPI Code, PMCPA, Trajenta, breach, diabetes

Boehringer Ingelheim has been publicly reprimanded for multiple breaches of the ABPI Code of Practice. In total the manufacturer fell …

News
Sanofi glucose monitor

Sanofi’s new diabetes device: worth the price?

March 12, 2012
Medical Communications NHS, Sanofi, app, diabetes, iBGStar, smartphone

Sanofi launched its new iPhone and iPod Touch blood sugar monitor to much fanfare this week, but its high price …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026